These results are in line with previously published data indicating that cytoplasmic localization of CDC25A is related to anti-apoptotic and pro-survival effects on ovarian and skin tumor cells [43,44], and therefore leads to a dependency of tumor progression on CDC25A. The gene discussed is CDC25A; the disease is neoplasm.